Skip to content
Toggle navigation
News
Press Releases
In the News
Contact
About
Company Overview
Leadership
Board of Directors
Scientific Advisory Board
Investors
Tailwind
Platform
NK cells
Publications & Presentations
Pipeline & Programs
Join us
Leading Together
Find your Position
About
Company Overview
Leadership
Board of Directors
Investors
Tailwind
Platform
NK cells
Publications & Presentations
Pipeline & Programs
Join us
Leading Together
Find your Position
News
Press Releases
Contact
Terms of Use
Privacy Policy
Publications & Presentations
Back to Publications & Presentations
CAT-248 (Engineered NK cells expressing CD70 CAR, IL15, and TGFβ DNR) demonstrates in vivo expansion, tumor infiltration, and durable regression of multiple CD70-expressing xenograft tumors
SITC 2023 Poster Presentation
Read More